FIELD: biochemistry.
SUBSTANCE: invention relates to the single-domain sdAb antibody to the human immunodeficiency virus type 1 reverse transcriptase capable of specifically binding to the human immunodeficiency virus type 1 antigen, as well as to use thereof for treating human immunodeficiency virus type 1, for preventing the development of human immunodeficiency virus type 1, as well as to use thereof for preventing recurrence of human immunodeficiency virus type 1. Also disclosed is an isolated polypeptide capable of specifically binding to antigen of reverse transcriptase of human immunodeficiency virus type 1.
EFFECT: invention enables effective treatment of type 1 human immunodeficiency virus.
20 cl, 10 dwg, 4 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SINGLE-DOMAIN ANTIBODIES DIRECTED AGAINST INTRACELLULAR ANTIGENS | 2016 |
|
RU2742248C2 |
| SINGLE-DOMAIN ANTIBODIES DIRECTED AGAINST INTRACELLULAR ANTIGENS | 2016 |
|
RU2742247C2 |
| SINGLE-DOMAIN ANTIBODIES AGAINST INTRACELLULAR ANTIGENS | 2015 |
|
RU2810002C2 |
| MONOCLONAL ANTIBODY, BINDING WITH EBOLA VIRUS GLYCOPROTEIN, DNA FRAGMENTS CODING THIS ANTIBODY, AND ANTIGEN-BINDING FRAGMENT | 2015 |
|
RU2630304C2 |
| MONOCLONAL ANTIBODY, BINDING WITH EBOLA VIRUS GLYCOPROTEIN, DNA FRAGMENTS CODING THIS ANTIBODY, AND ANTIGEN-BINDING FRAGMENT | 2015 |
|
RU2639533C2 |
| MONOCLONAL ANTIBODY, LINKING WITH E-BIR VIRUS GLOBE-PROTEIN, DNA FRAGMENTS CODING THIS ANTIBODY AND ANTIGEN-BINDING FRAGMENT | 2016 |
|
RU2644334C2 |
| VACCINE AGAINST HIV/AIDS | 2010 |
|
RU2475264C2 |
| SINGLE-DOMAIN ANTIBODY AND DERIVATIVES THEREOF TO LIGAND-1 PROTEIN OF PROGRAMMED CELL DEATH (PDLI) | 2016 |
|
RU2715595C2 |
| MONOCLONAL ANTIBODIES SPECIFIC TO PROTEIN RUSTICYANIN, AND USE OF ANTIBODIES FOR DIAGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMS | 2024 |
|
RU2823344C1 |
| SINGLE-DOMAIN ANTIBODIES TO EBOLA VIRUS GP PROTEIN FOR IMMUNOTHERAPY OF EBOLA FEVER | 2015 |
|
RU2644202C2 |
